Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Changing treatment news


From To
Can atazanavir reverse body fat changes?

Switching to the protease inhibitor atazanavir (Reyataz) can result in rapid improvement in lipodystrophy-associated body shape abnormalities and blood lipids, according to a short series

08 April 2004
Michael Carter
Meta-analysis finds PI-based HAART better than NNRTI regimens in NRTI experienced

Protease inhibitor (PI)-based highly active antiretroviral therapy (HAART) regimens are superior to non-nucleoside reverse transcriptase inhibitor (NNRTI)-based triple combinations, according to a meta-analysis of 14

30 January 2004
Michael Carter
More bad news on tenofovir/abacavir/3TC

Replacing a suppressive anti-HIV regimen with tenofovir/abacavir/3TC is a risky strategy according to a small, retrospective study published in The Lancet this week. Dutch researchers identified

16 December 2003
Megan Nicholson
Minority can have CD4 rises and no illness for more than 3 years after treatment failure

People with a stable low detectable viral load who continue with existing treatment continue to have rising CD4 cell counts and no clinical progression for

11 December 2003
Edwin J. Bernard
Gastrointestinal side-effects lead one in eight to change HAART regimen in first year of treatment

Over 50% of patients taking anti-HIV treatments for the first time will change or stop taking their drugs in the first year of therapy, often

27 November 2003
Michael Carter
← Prev1...2728293031Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.